Drug Type Live biotherapeutic products |
Synonyms- |
Target- |
Mechanism Bacteria replacements |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Uterine Neoplasms | Preclinical | US | 22 Apr 2024 |